Cover Image
市場調查報告書

全身性強直.陣攣性發作:全球臨床實驗檢討

Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 308255
出版日期 內容資訊 英文 121 Pages
訂單完成後即時交付
價格
Back to Top
全身性強直.陣攣性發作:全球臨床實驗檢討 Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月14日 內容資訊: 英文 121 Pages
簡介

本報告提供全身性強直.陣攣性發作相關臨床研究之最新趨勢分析,提供您疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7個國家)的臨床實驗數及實驗對像採用狀況,地區、Phase、階段別進展,有潛力的贊助商,再彙整各企業研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 全身性強直.陣攣性發作
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統臨床實驗數量中,全身性強直.陣攣性發作臨床實驗數量所佔的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:進展狀況別

E7(新興7個國家)各國臨床實驗數量:中樞神經系統臨床實驗數量中,全身性強直.陣攣性發作臨床實驗數量所佔的比例

E7(新興7個國家)各國臨床實驗數量:Phase別

E7(新興7個國家)各國臨床實驗數量:進展狀況別

Phase別臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • UCB S.A.
    • Novartis AG
    • Johnson & Johnson
    • Pfizer Inc.
    • Eisai
    • UCB Biosciences GmbH
    • SymPhar Sp. z.o.o.
    • GlaxoSmithKline plc
    • Desitin Arzneimittel GmbH
    • Alfred E. Tiefenbacher (GmbH & Co. KG)
  • 有代表性的研究機關·醫院臨床實驗概要
    • Dutch Epilepsy Clinics Foundation
    • Yonsei University
    • Emory University
    • Hadassah Medical Organization
    • Assistance Publique - Hopitaux de Paris
    • Gillette Children's Specialty Healthcare

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2234CTIDB

GlobalData's clinical trial report, "Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014" provides data on the Generalized Tonic-Clonic Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Generalized Tonic-Clonic Seizure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Generalized Tonic-Clonic Seizure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Generalized Tonic-Clonic Seizure
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Generalized Tonic-Clonic Seizure
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • UCB S.A.
      • Clinical Trial Overview of UCB S.A.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • UCB Biosciences GmbH
      • Clinical Trial Overview of UCB Biosciences GmbH
      • SymPhar Sp. z.o.o.
      • Clinical Trial Overview of SymPhar Sp. z.o.o.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Desitin Arzneimittel GmbH
      • Clinical Trial Overview of Desitin Arzneimittel GmbH
      • Alfred E. Tiefenbacher (GmbH & Co. KG)
      • Clinical Trial Overview of Alfred E. Tiefenbacher (GmbH & Co. KG)
    • Clinical Trial Overview of Top Institutes / Government
      • Dutch Epilepsy Clinics Foundation
      • Clinical Trial Overview of Dutch Epilepsy Clinics Foundation
      • Yonsei University
      • Clinical Trial Overview of Yonsei University
      • Emory University
      • Clinical Trial Overview of Emory University
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Gillette Children's Specialty Healthcare
      • Clinical Trial Overview of Gillette Children's Specialty Healthcare
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Region, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Generalized Tonic-Clonic Seizure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB Biosciences GmbH, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by SymPhar Sp. z.o.o., 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Desitin Arzneimittel GmbH, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfred E. Tiefenbacher (GmbH & Co. KG), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Dutch Epilepsy Clinics Foundation, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Gillette Children's Specialty Healthcare, 2014*

List of Figures

  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Generalized Tonic-Clonic Seizure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top